Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × eribulin × Sarcoma × Clear all

Phase

Status

Sponsor Class

OTHER 8 INDUSTRY 7 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Breast 1

Conditions

Solitary Fibrous Tumors 1 Sarcoma 1

Interventions

Radiotherapy 31 Doxorubicin 28 Ifosfamide 27 Filgrastim 21 Cyclophosphamide 21 Vincristine 20 Etoposide 18 Temozolomide 13 Granulocyte Colony-Stimulating Factor 12 Cisplatin 11 Dactinomycin 10 Trabectedin 9 Methotrexate 9 Gene Expression Profiling 9 Radiation 7 Polymerase Chain Reaction 7 Paclitaxel 7 Irinotecan 7 Imatinib Mesylate 7 Surgical Procedures, Operative 6 Immunohistochemistry 6 Chemotherapy, Adjuvant 6 Carmustine 6 sargramostim 5 etoposide phosphate 5 Topotecan 5 Mesna 5 Leucovorin 5 Gemcitabine 5 Cytarabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03840772 2024-09-20

ERASING

Italian Sarcoma Group

Phase 2 Completed

Sarcoma, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡